St. Jude Medical CEO Daniel Starks tells analysts that the medical device company doesn’t need to follow it’s competitors down the path of consolidation. St. Jude CEO Starks: It’s the size of the market, not the company that matters
St. Jude Medical (NYSE:STJ) CEO Daniel Starks told analysts last week that they shouldn’t expect the company to follow competitors like Medtronic (NYSE:MDT) down the consolidation path.
Starks said the markets St. Jude serves, along with recent acquisitions it’s made in smaller tuck-in deals gives it all the dry powder it needs to keep growing.
Help employers find you! Check out all the jobs and post your resume.
